96 related articles for article (PubMed ID: 9638975)
21. Hepatocyte growth factor/scatter factor (HGF/SF) affects proliferation and migration of myeloid leukemic cells.
Weimar IS; Voermans C; Bourhis JH; Miranda N; van den Berk PC; Nakamura T; de Gast GC; Gerritsen WR
Leukemia; 1998 Aug; 12(8):1195-203. PubMed ID: 9697873
[TBL] [Abstract][Full Text] [Related]
22. Comparison of in vitro growth characteristics of blast cell progenitors (CFU-L) in patients with myelodysplastic syndromes and acute myeloid leukemia.
Aul C; Gattermann N; Schneider W
Blood; 1992 Aug; 80(3):625-33. PubMed ID: 1638020
[TBL] [Abstract][Full Text] [Related]
23. CD34/CD117 positivity in assessment of prognosis in children with myelodysplastic syndrome.
Tavil B; Cetin M; Tuncer M
Leuk Res; 2006 Feb; 30(2):222-4. PubMed ID: 16098587
[TBL] [Abstract][Full Text] [Related]
24. Detection of molecular targets on the surface of CD34+CD38- bone marrow cells in myelodysplastic syndromes.
Xie W; Wang X; Du W; Liu W; Qin X; Huang S
Cytometry A; 2010 Sep; 77(9):840-8. PubMed ID: 20662087
[TBL] [Abstract][Full Text] [Related]
25. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
[TBL] [Abstract][Full Text] [Related]
26. Granulocyte colony-stimulating factor receptors on CD34++ cells in patients with myelodysplastic syndrome (MDS) and MDS-acute myeloid leukemia.
Kimura A; Sultana TA
Leuk Lymphoma; 2004 Oct; 45(10):1995-2000. PubMed ID: 15370243
[TBL] [Abstract][Full Text] [Related]
27. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
28. Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemopoiesis in the myelodysplastic syndromes.
Nagler A; Ginzton N; Negrin R; Bang D; Donlon T; Greenberg P
Leukemia; 1990 Mar; 4(3):193-202. PubMed ID: 1690318
[TBL] [Abstract][Full Text] [Related]
29. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
[TBL] [Abstract][Full Text] [Related]
30. CD34+ cells from patients with myelodysplastic syndrome present different p21 dependent premature senescence.
Xiao Y; Wang J; Song H; Zou P; Zhou D; Liu L
Leuk Res; 2013 Mar; 37(3):333-40. PubMed ID: 23219618
[TBL] [Abstract][Full Text] [Related]
31. Discordant expression of AC133 and AC141 in patients with myelodysplastic syndrome (MDS) and acute myelogeneous leukemia (AML).
Green CL; Loken M; Buck D; Deeg HJ
Leukemia; 2000 Apr; 14(4):770-2. PubMed ID: 10764169
[No Abstract] [Full Text] [Related]
32. Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis.
Hassan HT; Zander A
Acta Haematol; 1996; 95(3-4):257-62. PubMed ID: 8677752
[TBL] [Abstract][Full Text] [Related]
33. [In vitro effects of hematopoietic growth factors on CD34+ cell from patients with myelodysplastic syndromes].
Yang X; Gu X; Pei X; Zhu L
Zhonghua Xue Ye Xue Za Zhi; 1997 Jul; 18(7):354-7. PubMed ID: 15624331
[TBL] [Abstract][Full Text] [Related]
34. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
Carlo-Stella C; Mangoni L; Almici C; Frassoni F; Fiers W; Rizzoli V
Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011
[TBL] [Abstract][Full Text] [Related]
35. Impairment in immuno-modulatory function of Flk1(+)CD31(-)CD34(-) MSCs from MDS-RA patients.
Han Q; Sun Z; Liu L; Chen B; Cao Y; Li K; Zhao RC
Leuk Res; 2007 Nov; 31(11):1469-78. PubMed ID: 17360037
[TBL] [Abstract][Full Text] [Related]
36. Myelodysplastic syndrome is not merely "preleukemia".
Albitar M; Manshouri T; Shen Y; Liu D; Beran M; Kantarjian HM; Rogers A; Jilani I; Lin CW; Pierce S; Freireich EJ; Estey EH
Blood; 2002 Aug; 100(3):791-8. PubMed ID: 12130488
[TBL] [Abstract][Full Text] [Related]
37. Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: possible role in ineffective hemopoiesis.
Ohshima K; Karube K; Shimazaki K; Kamma H; Suzumiya J; Hamasaki M; Kikuchi M
Leuk Lymphoma; 2003 Aug; 44(8):1339-46. PubMed ID: 12952227
[TBL] [Abstract][Full Text] [Related]
38. Impaired generation of bone marrow CD34-derived dendritic cells with low peripheral blood subsets in patients with myelodysplastic syndrome.
Micheva I; Thanopoulou E; Michalopoulou S; Kakagianni T; Kouraklis-Symeonidis A; Symeonidis A; Zoumbos N
Br J Haematol; 2004 Sep; 126(6):806-14. PubMed ID: 15352984
[TBL] [Abstract][Full Text] [Related]
39. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
40. Granulocyte-monocyte and Granulocyte-Colony Stimulating Factors in Myelodysplastic Syndromes.
Nagler A; Greenberg PL
Leuk Lymphoma; 1991; 5(4):219-30. PubMed ID: 27467843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
